Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV.

Juan Macías Marta Fernández-Fuertes Noemí Oliver Anaïs Corma-Gómez Luis M Real Juan A Pineda

Clin Microbiol Infect

Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme, Seville, Spain; Department of Surgery, Biochemistry and Immunology, School of Medicine, University of Malaga, Malaga, Spain; CIBERINFEC, Spain.

Published: May 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828385	PMC
http://dx.doi.org/10.1016/j.cmi.2022.01.028	DOI Listing

Publication Analysis

Top Keywords

lower probability

probability persistence

persistence total

total anti-sars-cov-2

anti-sars-cov-2 antibodies

antibodies covid-19

covid-19 people

people living

living hiv

lower

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!